Increased CD14+HLA-DR-/low myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients

Overview of attention for article published in Cancer Immunology, Immunotherapy, June 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

patent: 9 patents

Citations

dimensions_citation: 186 Dimensions

Readers on

mendeley: 113 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 9 patents that reference this research output.

Selection of patients for combination therapy

Grant US-11397184-B2

United States of America

BIOMARKERS FOR LUNG CANCER STEM CELLS

Application TW-I727132-B

Chinese Taipei

BIOMARKERS FOR LUNG CANCER STEM CELLS

Application EP-3566053-A4

European Patent Office

CLINICAL CORRELATES OF IMMUNOTHERAPY EFFICACY

Application EP-3699294-A1

European Patent Office

Biomarkers for lung cancer stem cells

Application JP-2020507081-A

Japan

SELECTION OF PATIENTS FOR COMBINATION THERAPY

Application EP-3345002-A4

European Patent Office

DETECTION OF LEUKOCYTE-DERIVED MICROVESICLES BY FLUO-SENSITIVE FLOW CYTOMETRY

Application WO-2018232013-A1

World Intellectual Property Organisation (WIPO)

IMMUNOTHERAPY FOR CANCER

Application WO-2017211816-A1

World Intellectual Property Organisation (WIPO)

Method and compositions for inducing differentiation of myeloid derived suppressor cell…

Application EP-3012271-A1

European Patent Office